Literature DB >> 11496054

Nocturnal non-dipping: what does it augur?

T G Pickering1, K Kario.   

Abstract

The non-dipping pattern of blood pressure (defined as a nocturnal fall of less than 10%) occurs in about 25% of hypertensives, with increased prevalence in certain sub-groups such as diabetics, African-Americans, and patients with renal disease. It almost certainly has multiple causes, including factors such as the levels of activity and arousal during both the day and the night, the depth and quality of sleep, and the activity of the sympathetic nervous system, among others. In patients with uncomplicated hypertension, the reproducibility is relatively low. There is evidence suggesting that the non-dipping pattern may have an adverse prognosis: thus, it appears to predict the progression of renal disease, to be associated with increased target-organ damage (in some studies), and also to predict increased cardiovascular morbidity. Antihypertensive drug treatment can normalize the non-dipping pattern, but the therapeutic consequences of this are unknown.

Entities:  

Mesh:

Year:  2001        PMID: 11496054     DOI: 10.1097/00041552-200109000-00010

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  29 in total

1.  Effects of sleep on the cardiovascular and thermoregulatory systems: a possible role for hypocretins.

Authors:  H Schwimmer; H M Stauss; F Abboud; S Nishino; E Mignot; J M Zeitzer
Journal:  J Appl Physiol (1985)       Date:  2010-08-12

Review 2.  Night-time blood pressure patterns and target organ damage: a review.

Authors:  Faye S Routledge; Judith A McFetridge-Durdle; C R Dean
Journal:  Can J Cardiol       Date:  2007-02       Impact factor: 5.223

3.  Longitudinal association of sleep-disordered breathing and nondipping of nocturnal blood pressure in the Wisconsin Sleep Cohort Study.

Authors:  Khin Mae Hla; Terry Young; Laurel Finn; Paul E Peppard; Mariana Szklo-Coxe; Maryan Stubbs
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

4.  Renal resistive index and nocturnal non-dipping: is there an association in essential hypertension?

Authors:  Baris Afsar; Nurhan F Ozdemir; Rengin Elsurer; Siren Sezer
Journal:  Int Urol Nephrol       Date:  2008-09-20       Impact factor: 2.370

5.  Understanding the connection between spiritual well-being and physical health: an examination of ambulatory blood pressure, inflammation, blood lipids and fasting glucose.

Authors:  Julianne Holt-Lunstad; Patrick R Steffen; Jonathan Sandberg; Bryan Jensen
Journal:  J Behav Med       Date:  2011-04-13

Review 6.  Ambulatory blood pressure monitoring: from old concepts to novel insights.

Authors:  Mehmet Kanbay; Kultigin Turkmen; Tevfik Ecder; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2011-07-06       Impact factor: 2.370

Review 7.  Obstructive sleep apnea and hypertension.

Authors:  Krzysztof Narkiewicz; Jacek Wolf; Francisco Lopez-Jimenez; Virend K Somers
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

8.  Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.

Authors:  Nitish R Mahapatra; Daniel T O'Connor; Sucheta M Vaingankar; Amiya P Sinha Hikim; Manjula Mahata; Saugata Ray; Eugenie Staite; Hongjiang Wu; Yusu Gu; Nancy Dalton; Brian P Kennedy; Michael G Ziegler; John Ross; Sushil K Mahata
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

9.  Personality traits and circadian blood pressure patterns: a 7-year prospective study.

Authors:  Antonio Terracciano; James Strait; Angelo Scuteri; Osorio Meirelles; Angelina R Sutin; Kirill Tarasov; Jun Ding; Michele Marongiu; Marco Orru; Maria Grazia Pilia; Francesco Cucca; Edward Lakatta; David Schlessinger
Journal:  Psychosom Med       Date:  2014-04       Impact factor: 4.312

Review 10.  Diabetic kidney disease and the cardiorenal syndrome: old disease, new perspectives.

Authors:  Ankur Jindal; Mariana Garcia-Touza; Nidhi Jindal; Adam Whaley-Connell; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-08-01       Impact factor: 4.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.